LEVOFLOXACINE KABI 5 mg/ml, solution for infusion 20 bottles of 50 ml
Active ingredients: Levofloxacin, Levofloxacin hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for infusion20 bottles of 50 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVOFLOXACINE KABI 5 mg/ml, solution pour perfusion
- Pharmaceutical form
- solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 20 flacon(s) polyéthylène basse densité (PEBD) de 50 ml
- Marketing authorisation holder
- FRESENIUS KABI FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 2019
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62546668CIP75505543CIP133400955055433Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVOFLOXACINE HÉMIHYDRATÉEsolution | 5,125 mg · 1 ml de solution | SA |
| LÉVOFLOXACINEsolution | 5 mg · 1 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.